Stem Cell Therapy for Heart Failure Gets a Gold-Standard Trial – Scientific American
|
Stem Cell Therapy for Heart Failure Gets a Gold-Standard Trial
Scientific American One company, Melbourne, Australia–based Mesoblast, is already in late-stage clinical trials, treating hundreds of chronic heart failure patients with stem cell precursors drawn from healthy donors' hip bones. A randomized trial that includes a placebo … |
